Results 211 to 220 of about 282,363 (268)
Some of the next articles are maybe not open access.

Antisense Oligonucleotides

Nephron Experimental Nephrology, 1998
Antisense technology was developed to inhibit gene expression by utilizing an oligonucleotide complementary to the mRNA which encodes the target gene. There are a few possible mechanisms for the inhibitory effects of antisense oligonucleotides. Among them, degradation of mRNA by RNase H is considered to be the major mechanism of action for antisense ...
N, Kashihara, Y, Maeshima, H, Makino
openaire   +2 more sources

Therapeutic Oligonucleotides

2011
A brief historical introduction describes early attempts to silence specific genes using the antisense oligonucleotides that flourished in the 1980s. Early aspirations for therapeutic applications were almost extinguished by the unexpected complexity of oligonucleotide pharmacology.
openaire   +2 more sources

Membrane Anchored Immunostimulatory Oligonucleotides for In Vivo Cell Modification and Localized Immunotherapy

Angewandte Chemie - International Edition, 2011
Haipeng Liu, Darrell Irvine
exaly  

RNA therapeutics: beyond RNA interference and antisense oligonucleotides

Nature Reviews Drug Discovery, 2012
Sidney Altman   +2 more
exaly  

Photoinduced Transcription by Using Temporarily Mismatched Caged Oligonucleotides

Angewandte Chemie - International Edition, 2005
Alexander Heckel
exaly  

Chromatography of oligonucleotides

Archives of Biochemistry and Biophysics, 1959
M, STAEHELIN, E A, PETERSON, H A, SOBER
openaire   +2 more sources

THERAPEUTIC OLIGONUCLEOTIDES

2017
D'ADDA DI FAGAGNA FABRIZIO   +3 more
openaire   +11 more sources

Home - About - Disclaimer - Privacy